FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 220 filers reported holding FIBROGEN INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,914 | -68.0% | 12,648 | 0.0% | 0.00% | – |
| Q2 2023 | $34,150 | -85.5% | 12,648 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $236,012 | +13.5% | 12,648 | -2.6% | 0.00% | +50.0% |
| Q4 2022 | $208,004 | -99.9% | 12,984 | -48.8% | 0.00% | 0.0% |
| Q3 2022 | $165,165,000 | +123157.5% | 25,356 | +100.5% | 0.00% | +100.0% |
| Q2 2022 | $134,000 | -17.3% | 12,648 | -5.9% | 0.00% | -50.0% |
| Q1 2022 | $162,000 | -3.6% | 13,448 | +12.6% | 0.00% | 0.0% |
| Q4 2021 | $168,000 | +9.8% | 11,948 | -20.1% | 0.00% | 0.0% |
| Q3 2021 | $153,000 | -73.2% | 14,948 | -30.3% | 0.00% | -66.7% |
| Q2 2021 | $571,000 | +46.8% | 21,448 | +91.2% | 0.01% | +20.0% |
| Q1 2021 | $389,000 | -11.6% | 11,219 | -3.3% | 0.01% | 0.0% |
| Q4 2020 | $440,000 | – | 11,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 305,784 | $8,143,000 | 8.63% |
| Vantage Consulting Group Inc | 605,713 | $16,130,000 | 2.81% |
| GREAT POINT PARTNERS LLC | 500,000 | $13,315,000 | 2.79% |
| HHLR ADVISORS, LTD. | 3,955,787 | $105,343,000 | 1.08% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $5,094,000 | 1.01% |
| Ikarian Capital, LLC | 250,000 | $6,657,000 | 0.54% |
| BHK Investment Advisors, LLC | 45,100 | $1,201,000 | 0.49% |
| Ikarian Capital, LLC | 193,800 | $5,161,000 | 0.42% |
| Omega Fund Management, LLC | 130,646 | $3,479,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 200,000 | $5,326,000 | 0.36% |